BDBM285513 4-[4-Cyano-2-({[(1S,2R)-3′,3′-dimethyl-6′-(3-pyridinyl)-2′,3′-dihydrospiro[cyclopropane-1,1′-inden]-2-yl]carbonyl}amino)phenyl]butanoic acid::US10077247, Example 39

SMILES CC1(C)C[C@]2(C[C@H]2C(=O)Nc2cc(ccc2CCCC(O)=O)C#N)c2cc(ccc12)-c1cccnc1

InChI Key InChIKey=RSCZKBTVWRNMLT-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 285513   

TargetProstaglandin E2 receptor EP4 subtype(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM285513(US10077247, Example 39 | 4-[4-Cyano-2-({[(1S,2R)-3...)
Affinity DataIC50: 5.70nMT: 2°CAssay Description:EP4 Antagonistic Activity Measurement Experiment Using Prostanoid Receptor Subtype Expressing CellsCHO cells expressing rat EP4 receptor subtypes wer...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2019
Entry Details
US Patent